Menu

1 / 3

The DEA banned a drug some opioid users called a miracle

#arstechnica#technology#says#drug#opioids
Reading 0:00
15s threshold

Researchers say the Schedule I ban could kill studies of a promising opioid treatment.

In 2012, as the driver of deaths in the opioid crisis began moving from prescription pills to heroin, Laura Bohn was tasked with finding safer drugs to manage pain.

Funded by the National Institute on Drug Abuse, in 2017 she and other scientists revealed in the science journal Cell that several compounds—including a particularly promising one called SR-17018—could relieve pain in mice without causing respiratory depression. That’s a big deal, because respiratory depression is typically what causes people using opioids to stop breathing and die.

Bohn, senior associate vice president of research at University of South Florida Health, says her team filed a patent on SR-17018.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.